Search results
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance UK· 5 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
MARKET REPORT: Nvidia shares recover after $577bn sell-off
This Is Money· 6 days agoShares in artificial intelligence chip designer Nvidia rose nearly 6 per cent after a three-day rout...
Nearly £5bn wiped off value of GSK as US restricts RSV vaccine jabs
This Is Money· 4 days agoNearly £5billion was wiped off the value of GSK after a top US health agency limited the scope of its blockbuster respiratory vaccine. In a further setback for the UK pharmaceutical giant, the ...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 6 days agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance UK· 5 days agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
Weekly review
ShareCast· 3 days agoThe FTSE 100 ended the week down 73.6 points, or 0.89%, closing at 8,164.12 on Friday. Scientific instruments group Judges Scientific has spent £2.25m on the purchase of Wales-based Rockwash ...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
Daily Telegraph· 7 days agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
Far-right win leaves France amid shock and chaos
Reuters· 19 hours agoFrance is fast heading towards a year of political, economic and maybe financial chaos. After the first round of parliamentary elections on Sunday, the prospect of a far-right government commanding ...
3 FTSE 100 bargains I’d love to add to my Stocks and Shares ISA in July
Motley Fool UK· 1 day agoLuxury goods brand Burberry Group (LSE: BRBY) was the second-worst performer on the entire FTSE 100...
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters· 4 days ago, opens new tab lung cancer treatment, which belongs to a lucrative class of cancer therapies that work like "guided missiles". The FDA cited findings from an inspection of a third-party manufacturing ...
